CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2019; 06(02): 131-139
DOI: 10.1055/s-0039-1688898
Review Article
Indian Society of Neuroanaesthesiology and Critical Care

Contemporary Management of Aneurysmal Subarachnoid Hemorrhage: A Literature Review

Nikki Yeo
1   Neurosciences Critical Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
,
Luke Terrett
1   Neurosciences Critical Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
,
Arun K. Gupta
2   Department of Anaesthesia and Neurosciences Critical Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
› Author Affiliations
Further Information

Publication History

Received: 26 February 2019

Accepted after revision: 21 March 2019

Publication Date:
03 June 2019 (online)

Abstract

Subarachnoid hemorrhage (SAH) results in significant morbidity and mortality, which leads to additional economic and psychological burden. Atraumatic SAH is normally secondary to a ruptured aneurysm. Diagnosis of aneurysmal subarachnoid hemorrhage (aSAH) is usually made by computed tomography (CT) of the head: noncontrast CT identifies the hemorrhage, and CT angiography identifies the aneurysm.

The management of aSAH is focused on securing the aneurysm and prevention of secondary brain injury. Definitive treatment of the aneurysm is done by endovascular coiling or surgical clipping, which should be performed as soon as possible with avoidance of hypertension and strict blood pressure management prior to aneurysm securement. Routine use of nimodipine is recommended by international guidelines as a neuroprotectant. Common neurological complications of aSAH are hydrocephalus, seizures, vasospasm, and delayed cerebral ischemia (DCI). Detection of DCI, especially in patients with poor-grade aSAH, can be challenging. In addition to clinical examination, multiple radiological modalities can be used, with digital subtraction angiography being the gold standard but CT perfusion gaining an increasingly important role. Extracranial complications including cardiac dysfunction, pulmonary edema, and electrolyte abnormalities are common, causing significant morbidity and mortality.

In this review, a PubMed literature search was conducted using the terms “subarachnoid hemorrhage” and “management,” with results limited to past 5 years. Journal articles were hand-selected by the authors based on relevance, and the references were reviewed to identify additional relevant publications. Historically important publications were also included.

 
  • References

  • 1 Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med 2017; 377 (03) 257-266
  • 2 Degen LAR, Dorhout Mees SM, Algra A, Rinkel GJE. Interobserver variability of grading scales for aneurysmal subarachnoid hemorrhage. Stroke 2011; 42 (06) 1546-1549
  • 3 Rivero-Arias O, Gray A, Wolstenholme J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc 2010; 8: 6
  • 4 Taufique Z, May T, Meyers E. et al. Predictors of poor quality of life 1 year after subarachnoid hemorrhage. Neurosurgery 2016; 78 (02) 256-264
  • 5 Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 2010; 41 (08) e519-e536
  • 6 Huhtakangas J, Lehto H, Seppä K. et al. Long-term excess mortality after aneurysmal subarachnoid hemorrhage: patients with multiple aneurysms at risk. Stroke 2015; 46 (07) 1813-1818
  • 7 Rinkel GJ, Djibuti M, Algra AA, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998; 29 (01) 251-256
  • 8 Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European Stroke Organization. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013; 35 (02) 93-112
  • 9 Connolly Jr ES, Rabinstein AA, Carhuapoma JR. et al; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43 (06) 1711-1737
  • 10 Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 1999; 30 (07) 1396-1401
  • 11 Zheng VZ, Wong GKC. Neuroinflammation responses after subarachnoid hemorrhage: a review. J Clin Neurosci 2017; 42: 7-11
  • 12 Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet 2017; 389 10069 655-666
  • 13 Bassi P, Bandera R, Loiero M, Tognoni G, Mangoni A. Warning signs in subarachnoid hemorrhage: a cooperative study. Acta Neurol Scand 1991; 84 (04) 277-281
  • 14 Perry JJ, Stiell IG, Sivilotti MLA. et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ 2011; 343: d4277
  • 15 Cortnum S, Sørensen P, Jørgensen J. Determining the sensitivity of computed tomography scanning in early detection of subarachnoid hemorrhage. Neurosurgery 2010; 66 (05) 900-902 discussion 903
  • 16 van der Wee N, Rinkel GJ, Hasan D, van Gijn J. Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan?. J Neurol Neurosurg Psychiatry 1995; 58 (03) 357-359
  • 17 Agid R, Andersson T, Almqvist H. et al. Negative CT angiography findings in patients with spontaneous subarachnoid hemorrhage: when is digital subtraction angiography still needed?. AJNR Am J Neuroradiol 2010; 31 (04) 696-705
  • 18 Takagi K, Tamura A, Nakagomi T. et al. How should a subarachnoid hemorrhage grading scale be determined?. A combinatorial approach based solely on the Glasgow coma scale. J Neurosurg 1999; 90 (04) 680-687
  • 19 Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988; 68 (06) 985-986
  • 20 Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28 (01) 14-20
  • 21 van Heuven AW, Dorhout Mees SM, Algra A, Rinkel GJE. Validation of a prognostic subarachnoid hemorrhage grading scale derived directly from the Glasgow coma scale. Stroke 2008; 39 (04) 1347-1348
  • 22 Lindsay KW, Teasdale G, Knill-Jones RP, Murray L. Observer variability in grading patients with subarachnoid hemorrhage. J Neurosurg 1982; 56 (05) 628-633
  • 23 Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6 (01) 1-9
  • 24 Frontera JA, Claassen J, Schmidt JM. et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery 2006; 59 (01) 21-27 discussion 21–27
  • 25 Kramer AH, Hehir M, Nathan B. et al. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg 2008; 109 (02) 199-207
  • 26 Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg 2013; 79 (02) 307-312
  • 27 Tang CC, Zhang TS, Zhou LF. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis. PLoS One 2014; 9 (06) e99536
  • 28 Darkwah Oppong M, Gümüs M, Pierscianek D. et al. Aneurysm rebleeding before therapy: a predictable disaster?. J Neurosurg. 2018 doi: 10.3171/2018.7.JNS181119
  • 29 Datar S, Rabinstein AA. Postinterventional critical care management of aneurysmal subarachnoid hemorrhage. Curr Opin Crit Care 2017; 23 (02) 87-93
  • 30 Baharoglu MI, Germans MR, Rinkel GJE. et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2013; (08) CD001245
  • 31 Anker-Møller T, Troldborg A, Sunde N, Hvas AM. Evidence for the use of tranexamic acid in subarachnoid and subdural hemorrhage: a systematic review. Semin Thromb Hemost 2017; 43 (07) 750-758
  • 32 Rabinstein AA, Lanzino G. Aneurysmal Subarachnoid hemorrhage: unanswered questions. Neurosurg Clin N Am 2018; 29 (02) 255-262
  • 33 Molyneux A, Kerr R, Stratton I. et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360 (9342) 1267-1274
  • 34 Molyneux AJ, Kerr RSC, Yu LM. et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005; 366 (9488) 809-817
  • 35 Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RSC. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet 2015; 385 (9969) 691-697
  • 36 Hall A, O'Kane R. The extracranial consequences of subarachnoid hemorrhage. World Neurosurg 2018; 109: 381-392
  • 37 Pierot L, Wakhloo AK. Endovascular treatment of intracranial aneurysms: current status. Stroke 2013; 44 (07) 2046-2054
  • 38 Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage part I: Incidence and effects. J Clin Neurosci 1994; 1 (01) 19-26
  • 39 Haegens NM, Gathier CS, Horn J, Coert BA, Verbaan D, van den Bergh WM. Induced hypertension in preventing cerebral infarction in delayed cerebral ischemia after subarachnoid hemorrhage. Stroke 2018; 49 (11) 2630-2636
  • 40 Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol 2010; 9 (05) 504-519
  • 41 Anderson GB, Ashforth R, Steinke DE, Findlay JM. CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage. Am J Neuroradiol 2000; 21 (06) 1011-1015
  • 42 Lui YW, Tang ER, Allmendinger AM, Spektor V. Evaluation of CT perfusion in the setting of cerebral ischemia: patterns and pitfalls. AJNR Am J Neuroradiol 2010; 31 (09) 1552-1563
  • 43 Dankbaar JW, de Rooij NK, Velthuis BK, Frijns CJM, Rinkel GJE, van der Schaaf IC. Diagnosing delayed cerebral ischemia with different CT modalities in patients with subarachnoid hemorrhage with clinical deterioration. Stroke 2009; 40 (11) 3493-3498
  • 44 Pickard JD, Murray GD, Illingworth R. et al. Oral nimodipine and cerebral ischaemia following subarachnoid haemorrhage. Br J Clin Pract 1990; 44 (02) 66-67
  • 45 Dorhout Mees SM, Rinkel GJE, Feigin VL. et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007; (03) CD000277
  • 46 Loan JJM, Wiggins AN, Brennan PM. Medically induced hypertension, hypervolaemia and haemodilution for the treatment and prophylaxis of vasospasm following aneurysmal subarachnoid haemorrhage: systematic review. Br J Neurosurg 2018; 32 (02) 157-164
  • 47 Tagami T, Kuwamoto K, Watanabe A. et al; SAH PiCCO Study Group. Effect of triple-H prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2014; 21 (03) 462-469
  • 48 Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 2010; 14 (01) R23
  • 49 Okazaki T, Kuroda Y. Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome. J Intensive Care 2018; 6 (01) 28
  • 50 Gathier CS, van den Bergh WM, van der Jagt M. et al; HIMALAIA Study Group. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke 2018; 49 (01) 76-83
  • 51 Diringer MN, Bleck TP, Claude Hemphill III J. et al; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011; 15 (02) 211-240
  • 52 Baumann A, Derelle A-L, Mertes P-M, Audibert G. Seeking new approaches: milrinone in the treatment of cerebral vasospasm. Neurocrit Care 2012; 16 (03) 351-353
  • 53 Reynolds MR, Buckley RT, Indrakanti SS. et al. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms. J Neurosurg 2015; 123 (04) 862-871
  • 54 Adami D, Berkefeld J, Platz J. et al. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: worth the risk?. J Neuroradiol 2019; 46 (01) 15-24
  • 55 Germanwala AV, Huang J, Tamargo RJ. Hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21 (02) 263-270
  • 56 Lu J, Ji N, Yang Z, Zhao X. Prognosis and treatment of acute hydrocephalus following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2012; 19 (05) 669-672
  • 57 Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke 1989; 20 (06) 747-753
  • 58 Gigante P, Hwang BY, Appelboom G, Kellner CP, Kellner MA, Connolly ES. External ventricular drainage following aneurysmal subarachnoid haemorrhage. Br J Neurosurg 2010; 24 (06) 625-632
  • 59 Dorai Z, Hynan LS, Kopitnik TA, Samson D. Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52 (04) 763-769 discussion 769–771
  • 60 Corsten L, Raja A, Guppy K. et al. Contemporary management of subarachnoid hemorrhage and vasospas: the UIC experience. Surg Neurol 2001; 56 (03) 140-148 discussion 148–150
  • 61 Dey M, Stadnik A, Riad F. et al; CLEAR III Trial Investigators. Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial. Neurosurgery 2015; 76 (03) 291-300 discussion 301
  • 62 Lai L, Morgan MK. Predictors of in-hospital shunt-dependent hydrocephalus following rupture of cerebral aneurysms. J Clin Neurosci 2013; 20 (08) 1134-1138
  • 63 Klopfenstein JD, Kim LJ, Feiz-Erfan I. et al. Comparison of rapid and gradual weaning from external ventricular drainage in patients with aneurysmal subarachnoid hemorrhage: a prospective randomized trial. J Neurosurg 2004; 100 (02) 225-229
  • 64 Chung DY, Mayer SA, Rordorf GA. External ventricular drains after subarachnoid hemorrhage: is less more?. Neurocrit Care 2018; 28 (02) 157-161
  • 65 Raper DMS, Starke RM, Komotar RJ, Allan R, Connolly Jr ES. Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg 2013; 79 (05) (06) 682-690
  • 66 Naidech AM, Kreiter KT, Janjua N. et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005; 36 (03) 583-587
  • 67 Rosengart AJ, Huo JD, Tolentino J. et al. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 2007; 107 (02) 253-260
  • 68 Kramer CL, Pegoli M, Mandrekar J, Lanzino G, Rabinstein AA. Refining the association of fever with functional outcome in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2017; 26 (01) 41-47
  • 69 Scaravilli V, Tinchero G, Citerio G. Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Fever management in SAH. Neurocrit Care 2011; 15 (02) 287-294
  • 70 Lai PMR, See AP, Silva MA. et al. Non-infectious fever in aneurysmal subarachnoid hemorrhage: association with cerebral vasospasm and clinical outcome. World Neurosurg 2018; 1-23
  • 71 Meier K, Lee K. Neurogenic fever. J Intensive Care Med 2017; 32 (02) 124-129
  • 72 Fernandez A, Schmidt JM, Claassen J. et al. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology 2007; 68 (13) 1013-1019
  • 73 Badjatia N. Hyperthermia and fever control in brain injury. Crit Care Med 2009; 37 (07) Suppl S250-S257
  • 74 Naidech AM, Bendok BR, Bernstein RA. et al. Fever burden and functional recovery after subarachnoid hemorrhage. Neurosurgery 2008; 63 (02) 212-217 discussion 217–218
  • 75 Krishnamoorthy V, Mackensen GB, Gibbons EF, Vavilala MS. Cardiac dysfunction after neurologic injury: what do we know and where are we going?. Chest 2016; 149 (05) 1325-1331
  • 76 Murthy SB, Shah S, Rao CPV, Bershad EM, Suarez JI. Neurogenic stunned myocardium following acute subarachnoid hemorrhage: pathophysiology and practical considerations. J Intensive Care Med 2015; 30 (06) 318-325
  • 77 Garg R, Bar B. Systemic complications following aneurysmal subarachnoid hemorrhage. Curr Neurol Neurosci Rep 2017; 17 (01) 7
  • 78 Raya AK, Diringer MN. Treatment of subarachnoid hemorrhage. Crit Care Clin 2014; 30 (04) 719-733